FeNO Measuring Devices Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 90.32 Million |
| Market Size (2029) | USD 162.18 Million |
| CAGR (2024 - 2029) | 12.42 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
FeNO Measuring Devices Market Analysis
The FeNO Measuring Devices Market size is estimated at USD 90.32 million in 2024, and is expected to reach USD 162.18 million by 2029, growing at a CAGR of 12.42% during the forecast period (2024-2029).
The market for FeNO (fractional exhaled nitric oxide) measuring devices is driven by the increasing prevalence of respiratory disorders, such as asthma and chronic obstructive pulmonary disease (COPD) globally. In addition, continuous advancements in FeNO technologies encourage healthcare providers to integrate these devices into clinical practice, thereby driving market growth.
The high prevalence of asthma and COPD, exacerbated by factors like urbanization, pollution, and lifestyle changes, is a primary driver for the FeNO measuring devices market. These devices help in early diagnosis and personalized treatment planning. For instance, according to the data published by the Australian Institute of Health and Welfare in June 2024, asthma represented 2.5% of the overall disease burden in Australia in 2023. In addition, asthma constituted 4.4% of the non-fatal burden and 0.3% of the fatal burden in Australia in 2023. Additionally, within the respiratory disease group, asthma accounted for 52% of non-fatal burden in Australia in 2023. This shows the high burden of asthma, which is expected to increase the need for FeNO devices for diagnosis and management, thereby boosting market growth.
Furthermore, complimentary technological advancements in integrating FeNO measurements with other healthcare solutions are expected to increase the demand for FeNO devices over the forecast period. For instance, in February 2024, ZEPHYRx and NIOX collaborated to incorporate NIOX's FeNO technology into the ZEPHYRx Respiratory Cloud Platform. This integration aims to streamline clinical research by consolidating various respiratory endpoints into a reliable source. The ZEPHYRx platform seamlessly captures data from NIOX devices, making it instantly available on the Provider Dashboard. Hence, technological advancements expand the application of FeNO devices, which is expected to see significant growth in the market over the forecast period.
Consequently, as respiratory diseases become more prevalent and technology advances, the demand for FeNO measuring devices surges, driving market growth throughout the forecast period. However, the high cost of these devices is expected to hinder market growth over the forecast period.
FeNO Measuring Devices Market Trends
Electrochemical Technology Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
Electrochemical sensor technology in FeNO devices detects the electrochemical reaction of nitric oxide when it comes into contact with specific electrode materials. This reaction generates a measurable electrical signal proportional to the nitric oxide concentration in the exhaled breath. Electrochemical technology plays a significant role in the FeNO devices market, offering several advantages such as high sensitivity, portability, and cost-effectiveness that contribute to its growth and adoption.
Some of the primary drivers of the segment include the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD), among other respiratory diseases, increasing research and development funding for respiratory diseases, and ongoing advancements in electrochemical sensor technology. For instance, according to the data published by the WHO in November 2023, smoking stands as a primary driver of COPD, a prevalent lung ailment characterized by breathing difficulties, which claims the lives of more than 3 million individuals annually. It was estimated that around 392 million individuals were coping with COPD, with a significant three-quarters of them residing in low- and middle-income nations in 2023. The rising burden of COPD is projected to drive the demand for FeNO devices equipped with electrochemical sensors due to their distinct advantages, fueling segment growth throughout the study period.
Furthermore, several companies specializing in manufacturing FeNO devices with electrochemical sensors are focusing on innovation and expanding their product portfolios with new product approvals and launches. For instance, in January 2022, Bedfont Scientific Ltd received FDA clearance for the NObreath FeNO monitor. The NObreath FeNO monitor employs an electrochemical sensor to quantify nitric oxide concentration in parts per billion (ppb). Hence, the new launches increase the availability of FeNO devices with electrochemical technology, which is likely to promote the segment's growth.
Therefore, the high burden of respiratory diseases, coupled with the adoption of electrochemical technology FeNO devices and new product launches, is expected to fuel the segment’s growth significantly over the forecast period.
North America is Projected to Hold a Major Share of the Market During the Forecast Period
The FeNO measuring devices market in North America is poised for continued growth, driven by technological advancements, growing research funding for asthma, supportive regulatory frameworks, increasing healthcare awareness, and the region's robust healthcare infrastructure. These factors collectively contribute to expanding opportunities for manufacturers and stakeholders in the respiratory diagnostics sector. Asthma and other respiratory conditions are prevalent in North America, affecting millions of individuals. FeNO measuring devices are crucial in diagnosing, managing, and monitoring these conditions, contributing to market growth.
The high burden of respiratory disorders, such as asthma and COPD, is anticipated to drive the usage of FeNO measuring devices. It is expected to boost market growth in the region. For instance, according to the data published by the Allergy & Asthma Network in March 2023, over 26 million Americans were diagnosed with asthma in 2023. In addition, one in 10 school-aged children in the United States have asthma annually. Similarly, as per the data published by Salud Puebla in May 2024, Mexico reported a total of 137,042 cases of asthma. The highest prevalence was among the 5 to 9 age group, accounting for 19.6% of cases, closely followed by the 25 to 44 age bracket at 17.5% in 2022. All age groups face a significant burden from asthma. As a result, the demand for FeNO devices in the region is set to rise, aiding in asthma diagnosis, management, and monitoring. This surge in demand is anticipated to drive market growth during the study period.
Furthermore, the company's strategic activities, such as collaborations and partnerships, help distribute the FeNO devices in the region, which is expected to drive market growth. For instance, in May 2024, Methapharm Respiratory, one of the crucial players in respiratory diagnostics, partnered with Bosch Healthcare Solutions, a wholly-owned subsidiary of Robert Bosch GmbH, for the distribution of Vivatmo Pro, a FeNO device in the United States.
Therefore, the high burden of asthma cases in North American countries like the United States and Mexico, along with the strategic activities of the market players, is expected to boost market growth in the region over the forecast period.
FeNO Measuring Devices Industry Overview
The market for FeNO measuring devices is semi-consolidated and dominated primarily by global players. Companies focus on continuous innovation to enhance device accuracy, reliability, and ease of use. This includes advancements in sensor technologies and device portability. Some of the major players in the market are Sunvou Medical Electronics Co. Ltd, Bedfont Scientific Ltd, Caire Diagnostics Inc., NIOX Group PLC (Circassia Limited), and Eco Medics AG.
FeNO Measuring Devices Market Leaders
-
NIOX Group plc (Circassia Limited)
-
Sunvou Medical Electronics Co., Ltd.
-
Eco Medics AG
-
Bedfont Scientific Ltd.
-
CAIRE Diagnostics Inc
*Disclaimer: Major Players sorted in no particular order
FeNO Measuring Devices Market News
- May 2024: Methapharm and Bosch launched its newest FDA-cleared FeNO device, Vivatmo Pro, in the United States.
- May 2023: GenWorks, a prominent healthcare solutions provider, launched FenomPro, a breath analyzer designed to test patients' FeNO levels and aid in the early detection of asthma.
FeNO Measuring Devices Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumption and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders
4.2.2 Increasing Technological Advancements and Adoption of FeNO devices
4.3 Market Restraints
4.3.1 High Cost of the Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Technology
5.1.1 Chemiluminescence
5.1.2 Electrochemical
5.2 By Measuring Device
5.2.1 Handheld FeNO Measuring Devices
5.2.2 Tabletop FeNO Measuring Devices
5.3 By Application
5.3.1 Asthma
5.3.2 Chronic Obstructive Pulmonary Disease (COPD)
5.3.3 Other Applications
5.4 By End User
5.4.1 Hospitals and Clinics
5.4.2 Diagnostic Centers
5.4.3 Other End Users
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Rest of the World
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bosch Healthcare Solutions GmbH
6.1.2 Bedfont Scientific Ltd
6.1.3 NIOX Group plc (Circassia Limited)
6.1.4 Medisoft Group
6.1.5 Sunvou Medical Electronics Co. Ltd
6.1.6 RuiBreath
6.1.7 Eco Medics AG
6.1.8 CAIRE Diagnostics Inc.
6.1.9 Biometry Inc.
6.1.10 Genworks Health
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
FeNO Measuring Devices Industry Segmentation
As per the report's scope, FeNO (fractional exhaled nitric oxide) measuring devices are medical instruments used to quantify the concentration of nitric oxide (NO) in a patient's exhaled breath. These devices are increasingly playing a key role in diagnosing, managing, and monitoring conditions like asthma and COPD by measuring the level of nitric oxide in exhaled breath, which correlates with airway inflammation.
The FeNO measuring devices market is segmented by technology, type of device, application, end user, and geography. By technology, the market is bifurcated into chemiluminescence and electrochemical. The market is segmented by measuring devices into handheld FeNO measuring devices and tabletop FeNO measuring devices. Based on application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and other applications. By end user, the market is segmented into hospitals and clinics, diagnostic centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Market sizing and forecasts were made for each segment based on value (USD).
| By Technology | |
| Chemiluminescence | |
| Electrochemical |
| By Measuring Device | |
| Handheld FeNO Measuring Devices | |
| Tabletop FeNO Measuring Devices |
| By Application | |
| Asthma | |
| Chronic Obstructive Pulmonary Disease (COPD) | |
| Other Applications |
| By End User | |
| Hospitals and Clinics | |
| Diagnostic Centers | |
| Other End Users |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of the World |
FeNO Measuring Devices Market Research FAQs
How big is the FeNO Measuring Devices Market?
The FeNO Measuring Devices Market size is expected to reach USD 90.32 million in 2024 and grow at a CAGR of 12.42% to reach USD 162.18 million by 2029.
What is the current FeNO Measuring Devices Market size?
In 2024, the FeNO Measuring Devices Market size is expected to reach USD 90.32 million.
Who are the key players in FeNO Measuring Devices Market?
NIOX Group plc (Circassia Limited), Sunvou Medical Electronics Co., Ltd., Eco Medics AG, Bedfont Scientific Ltd. and CAIRE Diagnostics Inc are the major companies operating in the FeNO Measuring Devices Market.
Which is the fastest growing region in FeNO Measuring Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in FeNO Measuring Devices Market?
In 2024, the North America accounts for the largest market share in FeNO Measuring Devices Market.
What years does this FeNO Measuring Devices Market cover, and what was the market size in 2023?
In 2023, the FeNO Measuring Devices Market size was estimated at USD 79.10 million. The report covers the FeNO Measuring Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the FeNO Measuring Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
FeNO Measuring Devices Industry Report
Statistics for the 2024 FeNO Measuring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. FeNO Measuring Devices analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
